Capital Guardian Trust’s Array Biopharma Inc ARRY Stock Holding History

Capital Guardian Trust’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-90,000	Closed	-$266K	–	809
2016 Q1	$266K	Sell	90,000 -85,000	-49%	-$255K	﹤0.01%	317
2015 Q4	$739K	Hold	175,000	–	–	0.01%	263
2015 Q3	$798K	Hold	175,000	–	–	0.01%	265
2015 Q2	$1.26M	Hold	175,000	–	–	0.01%	240
2015 Q1	$1.29M	Sell	175,000 -125,000	-42%	-$890K	0.01%	233
2014 Q4	$1.42M	Sell	300,000 -135,000	-31%	-$534K	0.01%	244
2014 Q3	$1.55M	Sell	435,000 -40,000	-8%	-$158K	0.01%	234
2014 Q2	$2.17M	Hold	475,000	–	–	0.01%	217
2014 Q1	$2.23M	Hold	475,000	–	–	0.02%	210
2013 Q4	$2.38M	Hold	475,000	–	–	0.02%	205
2013 Q3	$2.96M	Sell	475,000 -25,000	-5%	-$149K	0.02%	197
2013 Q2	$2.27M	Buy	+500,000	New	+$2.69M	0.02%	198

Other funds holding ARRY

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Capital Guardian Trust's ARRY Position: Q2 2016 in Review

Capital Guardian Trust sold out of Array Biopharma Inc (ARRY) in Q2 2016, closing a stake of 90,000 shares — an estimated $266K sold.

Capital Guardian Trust first reported a position in ARRY in Q2 2013 and held it in 12 quarters. The position peaked at $2.96M in Q3 2013. 128 funds tracked by Wall St. Rank hold ARRY as of Q2 2016.

Capital Guardian Trust reported no remaining Array Biopharma Inc position as of Q2 2016 after selling out during the quarter.
Capital Guardian Trust sold 90,000 Array Biopharma Inc shares in Q2 2016, an estimated $266K.
Capital Guardian Trust first reported a position in Array Biopharma Inc in Q2 2013 and held it in 12 quarters.
Capital Guardian Trust's Array Biopharma Inc position peaked at $2.96M in Q3 2013.
128 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2016.

Based on Capital Guardian Trust's 13F filing for Q2 2016, filed 15 Aug 2016.